Osteoarthritis, especially of the knee is gradually becoming popular not only in Vietnam but also worldwide. Glucosamin has been proven by scientists as being effective in improving joint and bone diseases. And DCL Glucosamin 500mg will be an option for the treatment of osteoarthritis of the knee for consumers in Vietnam.
According to the World Health Organization, about 20% of the population suffers from osteoarthritis. This is a very common among bone and joint diseases with frequency of disease increasing along with age. Particularly in Vietnam, about 23.3% of people over 40 years old suffer from this. Due to the threat of the disease given by the World Health Organization data for the first 10 years of the 21st century, this period is considered the decade of arthritis. As the result, scientists around the world have been constantly doing research on treatment aiming at preventing the widespread of this disease. Glucosamin was discovered with a wide range of different features and effects, to cure different problems, especially bone and joint- related symptoms.
Glucosamin is widely used today and is the preferred choice of people with chronic arthritis, chronic osteoarthritis of the knee. Glucosamin stimulates cells in cartilage, joints, increases synthesis and polymerization of normal proteoglycan structure. Glucosamin also inhibits enzymes that destroy joint cartilage such as collagenase, phospholipase A2 as well as reduces superoxid free radicals which destroy cartilage cells.
Because of the benefits of Glucosamin in the treatment of osteoarthritis, DCL has launched the product line of Glucosamin 500mg with the goal of supporting stimulation of bone connective tissue reproduction, reducing calcium loss of bone; it also boosts the production of mucus which results in the increase of the viscosity and the lubrication of the drug. Therefore, DCL Glucosamin 500mg is not only effective in reducing symptoms of osteoarthritis (pain, difficulty in movement) but also prevents osteoarthritis process, cures both acute and chronic osteoarthritis diseases, improve joint function and prevents disease progression, restores articular cartilage structure.
Cuu Long Pharmaceutical Joint Stock Company has been striving to improve Vietnamese people’s health. The company constantly improves product quality, launches the best product lines to support and protect the health of the community. With the successes achieved during 40 years of development, especially since becoming a member of FIT Group, DCL is committed to continuing its efforts to become a reputable and high-evaluated pharmaceutical company by patients, employees and partners thanks to the best products, services, accessible and the best care, to be one of the leading pharmaceutical companies in Vietnam.